Low Dose Dexmedetomidine as a Postoperative Pain Adjunct
Spinal Fusion, Adolescent Idiopathic Scoliosis
About this trial
This is an interventional treatment trial for Spinal Fusion focused on measuring Pain management, Narcotic sparing, Pediatric, Dexmedetomidine
Eligibility Criteria
Inclusion Criteria: Diagnosis of idiopathic scoliosis Undergoing a posterior spinal fusion of at least 5 levels with both thoracic and lumbar involvement Exclusion Criteria: Known allergy to dexmedetomidine or any of the standard medications used intra or post operatively Patients with a history of chronic pain currently taking opioids, TCA's, Gabapentinoids Medical contraindications to administration of dexmedetomidine, unstable cardiac status, (prolonged Qtc, life threatening arrhythmias, use of digoxin) Moya Moya disease
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Dexmedetomidine
Control
Patient receives low dose dexmedetomidine infusion in addition to normal post-operative pain management protocol
Patient receives normal saline infusion in addition to normal post-operative pain management protocol